AU2003229761A1 - Peptide variants of ige constrained by beta-lactam bond - Google Patents

Peptide variants of ige constrained by beta-lactam bond

Info

Publication number
AU2003229761A1
AU2003229761A1 AU2003229761A AU2003229761A AU2003229761A1 AU 2003229761 A1 AU2003229761 A1 AU 2003229761A1 AU 2003229761 A AU2003229761 A AU 2003229761A AU 2003229761 A AU2003229761 A AU 2003229761A AU 2003229761 A1 AU2003229761 A1 AU 2003229761A1
Authority
AU
Australia
Prior art keywords
ige
constrained
beta
peptide variants
lactam bond
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003229761A
Other versions
AU2003229761A8 (en
Inventor
Ralph Biemans
Lena Susanna Chomez
Carlota Vinals Y De Bassols
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GlaxoSmithKline Biologicals SA
Original Assignee
GlaxoSmithKline Biologicals SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GlaxoSmithKline Biologicals SA filed Critical GlaxoSmithKline Biologicals SA
Publication of AU2003229761A1 publication Critical patent/AU2003229761A1/en
Publication of AU2003229761A8 publication Critical patent/AU2003229761A8/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/42—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
    • C07K16/4283—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an allotypic or isotypic determinant on Ig
    • C07K16/4291—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an allotypic or isotypic determinant on Ig against IgE
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2003229761A 2002-04-30 2003-04-28 Peptide variants of ige constrained by beta-lactam bond Abandoned AU2003229761A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0209878.8 2002-04-30
GBGB0209878.8A GB0209878D0 (en) 2002-04-30 2002-04-30 Vaccine
PCT/EP2003/004551 WO2003092714A2 (en) 2002-04-30 2003-04-28 Peptide variants of ige constrained by beta-lactam bond

Publications (2)

Publication Number Publication Date
AU2003229761A1 true AU2003229761A1 (en) 2003-11-17
AU2003229761A8 AU2003229761A8 (en) 2003-11-17

Family

ID=9935802

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003229761A Abandoned AU2003229761A1 (en) 2002-04-30 2003-04-28 Peptide variants of ige constrained by beta-lactam bond

Country Status (3)

Country Link
AU (1) AU2003229761A1 (en)
GB (1) GB0209878D0 (en)
WO (1) WO2003092714A2 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG149892A1 (en) * 2004-02-02 2009-02-27 Tanox Inc Identification of novel ige epitopes
NZ592977A (en) 2008-12-09 2013-01-25 Pfizer Vaccines Llc IgE CH3 PEPTIDE VACCINE
NZ618391A (en) 2009-07-30 2015-07-31 Pfizer Vaccines Llc Antigenic tau peptides and uses thereof
KR101660578B1 (en) 2009-09-03 2016-09-27 화이자 백신스 엘엘씨 Pcsk9 vaccine
EP2575868A1 (en) 2010-06-07 2013-04-10 Pfizer Vaccines LLC Ige ch3 peptide vaccine
WO2012131504A1 (en) 2011-03-02 2012-10-04 Pfizer Inc. Pcsk9 vaccine
WO2015123291A1 (en) 2014-02-11 2015-08-20 The Usa, As Represented By The Secretary, Dept. Of Health And Human Services Pcsk9 vaccine and methods of using the same

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0269455A3 (en) * 1986-11-28 1989-09-06 Takeda Chemical Industries, Ltd. Highly purified fused protein comprising human ige fc fragment and production thereof
US6500660B1 (en) * 1996-11-27 2002-12-31 Université Catholique de Louvain Chimeric target molecules having a regulatable activity
BR0008963A (en) * 1999-02-25 2001-11-27 Smithkline Beecham Biolog Epitopes or mimotopes derived from the ige dec-epsilon-2 domain, antagonists thereof, and their therapeutic uses
AU3281100A (en) * 1999-02-25 2000-09-14 Peptide Therapeutics Limited Epitopes or mimotopes derived from the c-epsilon-3 or c-epsilon-4 domains of ige, antagonists thereof, and their therapeutic uses
GB0020717D0 (en) * 2000-08-22 2000-10-11 Smithkline Beecham Biolog Novel compounds and process
GB0026334D0 (en) * 2000-10-27 2000-12-13 Smithkline Beecham Biolog Vaccine
JP2003047482A (en) * 2001-05-22 2003-02-18 Pfizer Prod Inc IgE VACCINE FREE FROM ANAPHYLAXIS-INDUCING PROPERTY

Also Published As

Publication number Publication date
WO2003092714A3 (en) 2004-03-18
WO2003092714A2 (en) 2003-11-13
GB0209878D0 (en) 2002-06-05
AU2003229761A8 (en) 2003-11-17

Similar Documents

Publication Publication Date Title
AU2003265235A1 (en) Non-affinity purification of proteins
AU2003225551A1 (en) Synthesis of 2h- and 13c- substituted dithianes
AU2003264939A1 (en) Watch
AU2003260907A1 (en) Broadcasting of software packages
AU2003302167A1 (en) Conversion of apoptotic proteins
AU2003239644A1 (en) Crystallization of sugars
AU2003230457A1 (en) Compression of containers
AU2003206803A1 (en) Production of alkenones
AU2003269126A1 (en) Method of combining materials
AU2003272454A1 (en) Protein purification
AU2003229761A1 (en) Peptide variants of ige constrained by beta-lactam bond
AU2003262911A1 (en) Methods of promoting osteogenesis
AU2003295638A1 (en) NOVEL INHIBITORS OF Beta-LACTAMASE
AU2003260909A1 (en) Method of enhancing multimedia
AU2003282338A1 (en) Determination of protein function
AU2003261801A1 (en) Novel depsipeptide compound
AU2003286273A1 (en) Decorrelation of signals
AU2003217174A1 (en) Novel variants of rankl protein
AU2003304374A1 (en) Peptide inhibitors of beta-lactamases
AU2003257541A1 (en) Novel crystals
AU2003262638A1 (en) Biotinylation of proteins
AU2003254001A1 (en) Novel htnfsf13b protein variants
EP1621608A4 (en) Novel fungus capable of breaking urethane bond
AU2003238034A1 (en) Novel use of imidazotriazinones
AU2003299746A1 (en) Total synthesis of daurichromenic acid

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase